MPO and stroke disorder: Studies have shown that the classic MPO inhibitor, 4-aminobenzoic acid hydrazide (ABAH), can inhibit MPO activity, increase the proliferation of stroke neurons, and improve neurogenesis (Forghani et al., 2015; Kim et al., 2016).